Skip to main content
OpenTrials
Completed

NCT Number: NCT02320994

Managing Aftercare for Stroke (MAS): MAS-I - a Cross Sectional Study of Post-rehabilitation Stroke Burden and Patients' Needs

In this first step of the study the investigators will assess the needs, disease burden and current treatments of long-term stroke patients (phase MAS-I).

The ultimate aim of the complete MAS project (MAS I, II & III) is the development of a model of stroke aftercare delivery that can be evaluated to estimate effects in both our local and the wider stroke population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ischemic Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Stroke Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Charité - Universitätsmedizin Berlin (Center for Stroke Research Berlin CSB & NeuroCure Clinical Research Center)

Berlin, 10117, Germany

About this study

After discharge from hospital the current healthcare system in Germany allows considerable flexibility (therefore complexity) of patient access and mobility between multiple care providers in the community setting. The investigators believe this aftercare could be better coordinated by a specialized coordinated stroke aftercare service. Comprehensive coordinated multidisciplinary care is a proven concept with proven benefits in both acute and rehabilitation care provided in stroke units and neurorehabilitation centres. In this study the investigators postulate that a similar coordinated approach to care can be extended to the phase after in-patient rehabilitation has ended (i.e. "long-term management" as opposed to "early supported discharge") for disabled patients with stroke living in the community.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years
  • Participation in one of the previously conducted stroke cohort studies: STRAWINSKI or PREDICT
  • Modified Rankin Score (mRS) recorded as = 1 - 5 (at last follow up during cohort study)
  • Informed consent signed by patient or legal representative

Exclusion criteria

  • Unwilling to have pseudonymised data stored, analyzed & anonymously published.
  • Patients participating in the previous studies recruited in centres outside Berlin

Treatment and study plan

Primary outcomes

  1. Prevalence of unmet Needs

    Time frame: once

    Unmet needs of patients and carers after discharge from Rehabilitation. Score of variables examined (self-reported stroke related need, post-stroke spasticity, post-stroke pain, post-stroke aphasia, neuropsychological impairment, post-stroke depression, post-stroke dementia, inadequate secondary prevention, social care need and carer burden).

Secondary outcomes

  1. post-stroke checklist

    Time frame: once

    Evaluation of post-stroke checklist as a valid tool to screen for relevant burden of disease after stroke.

  2. Standard practice evaluation

    Time frame: once

    Comparison of Standard practice in relation to evidence-based recommendations and current Clinical Guidelines for the management of stroke.

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Collaborators

  • NeuroCure Clinical Research Center, Charite, Berlin
  • Prof. Dr. Ian Wellwood
  • Prof. Dr. Jörg Wissel

Registry information

Acronym: MAS-I

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Dec 19, 2014
Registry last updated
Jan 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.